DK1173439T3 - Halogenalkoxy-imidazonaphthyridiner - Google Patents

Halogenalkoxy-imidazonaphthyridiner

Info

Publication number
DK1173439T3
DK1173439T3 DK00918882T DK00918882T DK1173439T3 DK 1173439 T3 DK1173439 T3 DK 1173439T3 DK 00918882 T DK00918882 T DK 00918882T DK 00918882 T DK00918882 T DK 00918882T DK 1173439 T3 DK1173439 T3 DK 1173439T3
Authority
DK
Denmark
Prior art keywords
imidazonaphthyridiner
haloalkoxy
compounds
useful
preventing
Prior art date
Application number
DK00918882T
Other languages
Danish (da)
English (en)
Inventor
Gerhard Grundler
Wolfgang-Alexander Simon
Stefan Postius
Wolfgang Kromer
Joerg Senn-Bilfinger
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK1173439T3 publication Critical patent/DK1173439T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Electroluminescent Light Sources (AREA)
  • Saccharide Compounds (AREA)
DK00918882T 1999-04-17 2000-04-14 Halogenalkoxy-imidazonaphthyridiner DK1173439T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99107688 1999-04-17
PCT/EP2000/003388 WO2000063211A1 (en) 1999-04-17 2000-04-14 Haloalkoxy imidazonaphthyridines

Publications (1)

Publication Number Publication Date
DK1173439T3 true DK1173439T3 (da) 2003-09-08

Family

ID=8237986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00918882T DK1173439T3 (da) 1999-04-17 2000-04-14 Halogenalkoxy-imidazonaphthyridiner

Country Status (12)

Country Link
US (1) US6503923B1 (de)
EP (1) EP1173439B1 (de)
JP (1) JP2002542248A (de)
AT (1) ATE240956T1 (de)
AU (1) AU3966600A (de)
CA (1) CA2370231A1 (de)
DE (1) DE60002855T2 (de)
DK (1) DK1173439T3 (de)
ES (1) ES2199810T3 (de)
PT (1) PT1173439E (de)
SI (1) SI1173439T1 (de)
WO (1) WO2000063211A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869949B2 (en) * 2000-10-25 2005-03-22 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MXPA03007888A (es) * 2001-03-08 2003-12-04 Astrazeneca Ab Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
PL366658A1 (en) 2001-08-02 2005-02-07 Altana Pharma Ag Tricyclic epoxides
BR0211620A (pt) * 2001-08-03 2004-08-24 Altana Pharma Ag Imidazopiridinas substituìdas por alquila para o tratamento de distúrbios gastrointestinais
WO2003014120A1 (en) * 2001-08-03 2003-02-20 Altana Pharma Ag Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
EA008375B1 (ru) 2002-02-15 2007-04-27 Алтана Фарма Аг Трициклические n-ацильные соединения
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
MXPA05005117A (es) 2002-11-19 2005-07-01 Altana Pharma Ag Imidazopiridinas 8-sustituidas.
US20060154954A1 (en) * 2003-02-17 2006-07-13 Altana Pharma Ag Combinations and use of selected pharmaceutically active compounds
CA2503290C (en) 2003-03-10 2012-12-04 Altana Pharma Ag Novel process for the preparation of roflumilast
MXPA05012463A (es) * 2003-05-27 2006-01-30 Altana Pharma Ag Combinaciones farmaceuticas de un inhibidor de bomba protonica y un compuesto que modifica la motilidad gastrointestinal.
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
US7326784B2 (en) 2003-12-19 2008-02-05 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
US7931659B2 (en) * 2004-09-10 2011-04-26 Penumbra, Inc. System and method for treating ischemic stroke
WO2006037748A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
EE04677B1 (et) * 1998-09-23 2006-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahdropridoeetrid, nende kasutamine ja ravim

Also Published As

Publication number Publication date
ATE240956T1 (de) 2003-06-15
CA2370231A1 (en) 2000-10-26
US6503923B1 (en) 2003-01-07
PT1173439E (pt) 2003-10-31
EP1173439A1 (de) 2002-01-23
EP1173439B1 (de) 2003-05-21
SI1173439T1 (en) 2003-10-31
ES2199810T3 (es) 2004-03-01
AU3966600A (en) 2000-11-02
DE60002855D1 (de) 2003-06-26
WO2000063211A1 (en) 2000-10-26
DE60002855T2 (de) 2004-05-06
JP2002542248A (ja) 2002-12-10

Similar Documents

Publication Publication Date Title
ATE240956T1 (de) Haloalkoxy-imidazonaphthyridine
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
ATE527250T1 (de) 2,4,6-trisubstituierten pyrimidinen als phosphotidylinositol (pi) 3-kinase inhibitoren und deren verwendung zur behandlung von krebs
AR023777A1 (es) Nuevos compuestos
DK0998460T3 (da) Hidtil ukendte tetrazolderivater
DE60121461D1 (de) Kondensierte pyridoindolderivate
TR200401316T4 (tr) Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler
ATE332302T1 (de) Alkylierte imidazopyridinderivate
ES2249309T3 (es) Compuestos de 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de csbp/p39 kinasa.
ATE391715T1 (de) Heterozyklische mutilinester und deren verwendung als bakterizide
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
DK1268472T3 (da) 3-aminopyrazolinhibitorer af cyclinafhængige kinaser
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
BR0012169A (pt) Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia
MXPA05009282A (es) Derivados de anilina sustituidos.
MXPA04005129A (es) Uso de diamina de acido piridin-2,4-dicarboxilico y de diaminas de acido pirimidin-4,6-dicarboxilico para la inhibicion selectiva de la colagenasa.
MY135375A (en) Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
ATE368649T1 (de) Cyanoguanidin prodrugs
PT1000046E (pt) Derivados de piperazina activos no trato urinario inferior
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
TR200103858T2 (tr) Hücre yapışmasının önleyicileri olarak ikame edilmiş purin türevleri
DK1244643T3 (da) Tryptaseinhibitorer
SG171472A1 (en) Substituted aniline derivatives